Annual EBITDA
-$108.27 M
-$32.04 M-42.04%
December 1, 2024
Summary
- As of March 10, 2025, IRON annual EBITDA is -$108.27 million, with the most recent change of -$32.04 million (-42.04%) on December 1, 2024.
- During the last 3 years, IRON annual EBITDA has fallen by -$77.37 million (-250.39%).
- IRON annual EBITDA is now -250.39% below its all-time high of -$30.90 million, reached on December 31, 2021.
Performance
IRON EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.25 M
+$19.59 M+59.66%
December 1, 2024
Summary
- As of March 10, 2025, IRON quarterly EBITDA is -$13.25 million, with the most recent change of +$19.59 million (+59.66%) on December 1, 2024.
- Over the past year, IRON quarterly EBITDA has stayed the same.
- IRON quarterly EBITDA is now -162.98% below its all-time high of $21.04 million, reached on December 1, 2021.
Performance
IRON Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$108.27 M
+$1.64 M+1.49%
December 1, 2024
Summary
- As of March 10, 2025, IRON TTM EBITDA is -$108.27 million, with the most recent change of +$1.64 million (+1.49%) on December 1, 2024.
- Over the past year, IRON TTM EBITDA has stayed the same.
- IRON TTM EBITDA is now -1037.81% below its all-time high of -$9.52 million, reached on March 1, 2020.
Performance
IRON TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IRON EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.0% | 0.0% | 0.0% |
| 3 y3 years | -250.4% | 0.0% | 0.0% |
| 5 y5 years | -221.4% | 0.0% | 0.0% |
IRON EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -250.4% | at low | -33.3% | +59.7% | -854.0% | +1.5% |
| 5 y | 5-year | -250.4% | at low | -163.0% | +59.7% | -1037.8% | +1.5% |
| alltime | all time | -250.4% | at low | -163.0% | +59.7% | -1037.8% | +1.5% |
Disc Medicine EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$108.27 M(+42.0%) | -$13.25 M(-59.7%) | -$108.27 M(-1.5%) |
| Sep 2024 | - | -$32.84 M(+6.8%) | -$109.92 M(+14.5%) |
| Jun 2024 | - | -$30.74 M(-2.2%) | -$96.00 M(+16.3%) |
| Mar 2024 | - | -$31.44 M(+111.1%) | -$82.57 M(+8.3%) |
| Dec 2023 | -$76.23 M(+60.9%) | -$14.89 M(-21.3%) | -$76.23 M(-0.1%) |
| Sep 2023 | - | -$18.93 M(+9.4%) | -$76.33 M(+12.5%) |
| Jun 2023 | - | -$17.30 M(-31.1%) | -$67.85 M(+8.5%) |
| Mar 2023 | - | -$25.10 M(+67.4%) | -$62.54 M(+32.0%) |
| Dec 2022 | -$47.39 M | -$15.00 M(+43.4%) | -$47.39 M(+317.5%) |
| Sep 2022 | - | -$10.46 M(-12.8%) | -$11.35 M(-41.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$11.99 M(+20.6%) | -$19.28 M(-18.1%) |
| Mar 2022 | - | -$9.94 M(-147.3%) | -$23.55 M(-23.4%) |
| Dec 2021 | -$30.90 M(-8.3%) | - | - |
| Dec 2021 | - | $21.04 M(-214.4%) | -$30.75 M(-31.0%) |
| Sep 2021 | - | -$18.39 M(+13.1%) | -$44.56 M(+30.9%) |
| Jun 2021 | - | -$16.26 M(-5.1%) | -$34.05 M(+39.7%) |
| Mar 2021 | - | -$17.14 M(-337.1%) | -$24.37 M(+45.5%) |
| Dec 2020 | -$33.69 M | $7.23 M(-191.7%) | -$16.75 M(-30.1%) |
| Sep 2020 | - | -$7.88 M(+19.6%) | -$23.98 M(+48.9%) |
| Jun 2020 | - | -$6.59 M(-30.8%) | -$16.10 M(+69.2%) |
| Mar 2020 | - | -$9.52 M | -$9.52 M |
FAQ
- What is Disc Medicine annual EBITDA?
- What is the all time high annual EBITDA for Disc Medicine?
- What is Disc Medicine annual EBITDA year-on-year change?
- What is Disc Medicine quarterly EBITDA?
- What is the all time high quarterly EBITDA for Disc Medicine?
- What is Disc Medicine quarterly EBITDA year-on-year change?
- What is Disc Medicine TTM EBITDA?
- What is the all time high TTM EBITDA for Disc Medicine?
- What is Disc Medicine TTM EBITDA year-on-year change?
What is Disc Medicine annual EBITDA?
The current annual EBITDA of IRON is -$108.27 M
What is the all time high annual EBITDA for Disc Medicine?
Disc Medicine all-time high annual EBITDA is -$30.90 M
What is Disc Medicine annual EBITDA year-on-year change?
Over the past year, IRON annual EBITDA has changed by -$32.04 M (-42.04%)
What is Disc Medicine quarterly EBITDA?
The current quarterly EBITDA of IRON is -$13.25 M
What is the all time high quarterly EBITDA for Disc Medicine?
Disc Medicine all-time high quarterly EBITDA is $21.04 M
What is Disc Medicine quarterly EBITDA year-on-year change?
Over the past year, IRON quarterly EBITDA has changed by $0.00 (0.00%)
What is Disc Medicine TTM EBITDA?
The current TTM EBITDA of IRON is -$108.27 M
What is the all time high TTM EBITDA for Disc Medicine?
Disc Medicine all-time high TTM EBITDA is -$9.52 M
What is Disc Medicine TTM EBITDA year-on-year change?
Over the past year, IRON TTM EBITDA has changed by $0.00 (0.00%)